Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 7
2008 5
2009 4
2010 8
2011 9
2012 11
2013 13
2014 9
2015 12
2016 12
2017 14
2018 9
2019 9
2020 10
2021 16
2022 14
2023 11
2024 15
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma.
White C, Jayaprakasam VS, Tenet M, Tang LH, Schattner MA, Janjigian YY, Maron SB, Schöder H, Larson SM, Gönen M, Datta J, Coit DG, Mauguen A, Strong VE, Vitiello GA. White C, et al. Among authors: strong ve. Eur J Surg Oncol. 2025 Jan 8;51(5):109589. doi: 10.1016/j.ejso.2025.109589. Online ahead of print. Eur J Surg Oncol. 2025. PMID: 39808889
Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young- and Average-Onset Gastric Cancer.
Magahis PT, Cornet N, Tang L, Arora K, Hingorani N, King S, Markowitz AJ, Schattner M, Shimada S, Maron SB, Vardhana S, Lumish M, Cercek A, Janjigian YY, Coit D, Mendelsohn RB, Berger MF, Strong VE, Stadler ZK, Laszkowska M. Magahis PT, et al. Among authors: strong ve. Cancer Med. 2024 Dec;13(23):e70451. doi: 10.1002/cam4.70451. Cancer Med. 2024. PMID: 39629931 Free PMC article.
D2 Lymphadenectomy for Gastric Cancer: Advancements and Technical Considerations.
Dehal A, Woo Y, Glazer ES, Davis JL, Strong VE; Society of Surgical Oncology Gastrointestinal Disease Site Workgroup. Dehal A, et al. Among authors: strong ve. Ann Surg Oncol. 2025 Mar;32(3):2129-2140. doi: 10.1245/s10434-024-16545-6. Epub 2024 Nov 26. Ann Surg Oncol. 2025. PMID: 39589578 Review.
Disappearing Signet Ring Cell Adenocarcinoma in Gastric Cancer Patients.
Sreeram A, Stroobant EE, Laszkowska M, Guilford P, Shimada S, Nishimura M, Shah S, Vardhana S, Tang LH, Strong VE. Sreeram A, et al. Among authors: strong ve. Ann Surg Oncol. 2024 Dec;31(13):9030-9038. doi: 10.1245/s10434-024-16117-8. Epub 2024 Sep 29. Ann Surg Oncol. 2024. PMID: 39343820
Feasibility and Efficacy of Sentinel Lymph Node Mapping in Gastric Cancer.
Abate M, Drebin H, Shimada S, Fei T, McKinley S, Poruk K, Ferguson B, Neuwirth M, Tang LH, Vardhana S, Strong VE. Abate M, et al. Among authors: strong ve. Ann Surg Oncol. 2024 Oct;31(10):6959-6969. doi: 10.1245/s10434-024-15642-w. Epub 2024 Aug 3. Ann Surg Oncol. 2024. PMID: 39097552
168 results